Bioceres Crop Solutions (NASDAQ:BIOX) Announces Earnings Results, Misses Estimates By $0.33 EPS

Bioceres Crop Solutions (NASDAQ:BIOX) posted its quarterly earnings results on Tuesday, September 15th. The company reported ($0.39) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.33), reports. The business had revenue of $55.90 million for the quarter, compared to analyst estimates of $79.00 million. Bioceres Crop Solutions had a negative return on equity of 39.11% and a negative net margin of 94.76%.

Here are the key takeaways from Bioceres Crop Solutions’ conference call:

• Fiscal 2026 revenue declined 18% to $238 million, while reported gross profit fell 21% to $82.9 million, reflecting the seed-business reconfiguration and weaker Crop Protection and inoculant sales.
• Fourth-quarter revenue was broadly stable year over year at $55.9 million, led by 36% growth in Crop Nutrition, while cost reductions helped adjusted EBITDA improve to positive $0.6 million from negative $9.6 million a year earlier.
• Management said the company is entering fiscal 2027 with a leaner cost structure and is targeting approximately 40% gross margins, supported by a simplified portfolio focused on higher-value products and core markets such as Brazil.
• Liquidity and capital structure remain significant risks, with $213.6 million of net financial debt and $118.6 million of secured notes classified as short term amid ongoing litigation over note acceleration and foreclosure.

Bioceres Crop Solutions Price Performance

NASDAQ BIOX traded down $0.02 during trading hours on Friday, hitting $0.21. 124,828 shares of the company were exchanged, compared to its average volume of 217,084. The company has a 50 day moving average of $0.35 and a two-hundred day moving average of $0.48. The company has a debt-to-equity ratio of 0.94, a current ratio of 0.81 and a quick ratio of 0.63. Bioceres Crop Solutions has a 52-week low of $0.19 and a 52-week high of $2.10.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research note on Friday, October 9th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus price target of $2.00.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an Argentina-based agricultural biotechnology company focused on developing technologies that improve crop productivity, resilience and sustainability. The company serves farmers and agricultural businesses through products designed to support crop establishment, nutrition, protection and performance under challenging environmental conditions.

Its portfolio includes the HB4 biotechnology platform, which is used in drought-tolerant wheat and soybean varieties, as well as biological seed treatments, microbial inoculants, biofertilizers, biostimulants and biological crop-protection products.